SPOCK3 (testican-3) is a secreted extracellular matrix proteoglycan that functions as a tumor-suppressive metalloendopeptidase inhibitor. It inhibits membrane-type matrix metalloproteinases (MT1-MMP and MT3-MMP), thereby preventing pro-MMP-2 activation and blocking tumor invasion. The protein contains a modular architecture including follistatin-like domain, acidic region, EC calcium-binding domains, Kazal-like protease inhibitor domain, and thyroglobulin type-1 domain. SPOCK3 carries chondroitin sulfate and heparan sulfate glycosaminoglycan chains and is highly expressed in normal brain, with expression decreasing in gliomas. A splice variant (N-Tes, isoform 2) lacks the thyroglobulin domain but retains MMP inhibitory activity. Unlike testican-2 (SPOCK2), which counteracts MMP inhibition, SPOCK3 shares with testican-1 (SPOCK1) the key function of suppressing MT-MMP-mediated tumor invasion and cell motility through direct interaction with MT-MMPs.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0031012
extracellular matrix
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: SPOCK3 is a secreted extracellular matrix proteoglycan. UniProt states "Secreted, extracellular space, extracellular matrix" and this is consistent with its function as an ECM-localized MMP inhibitor.
Reason: This is a core cellular component annotation for SPOCK3. The protein is secreted into the ECM where it carries out its primary function of inhibiting membrane-type MMPs. This localization is essential for its tumor-suppressive role and is supported by phylogenetic inference (IBA) as well as experimental evidence from PMID:11751414 showing SPOCK3/N-Tes is deposited on collagen and from PMID:12810672 demonstrating ECM deposition. The annotation is further supported by high-throughput proteomics studies (PMID:32055794, PMID:33266304) identifying SPOCK3 in ECM fractions.
Supporting Evidence:
PMID:11751414
Expression of N-Tes and testican 3 was detected in normal brain but down-regulated in glioma tissues. Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel.
PMID:12810672
Testican 2 was not incorporated into collagen by itself, and was deposited only in the presence of N-Tes, suggesting that testican 2 binds to N-Tes deposited on collagen.
file:human/SPOCK3/SPOCK3-deep-research-falcon.md
model: Edison Scientific Literature
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: This is THE core molecular function of SPOCK3. Experimentally demonstrated to inhibit MT1-MMP and MT3-MMP, preventing pro-MMP-2 activation. This is the key tumor-suppressive function of SPOCK3.
Reason: This is absolutely a core function annotation that must be retained. SPOCK3 was originally characterized as an inhibitor of membrane-type matrix metalloproteinases (PMID:11751414). The paper demonstrates direct interaction of SPOCK3/N-Tes with MT1-MMP and MT3-MMP, inhibiting their ability to activate pro-MMP-2. PMID:12810672 confirms this function is common among testican family members except testican-2. UniProt states "Inhibits the processing of pro-matrix metalloproteinase 2 (MMP-2) by MT1-MMP and MT3-MMP." This metalloendopeptidase inhibitor activity is the mechanistic basis for SPOCK3's tumor suppression and represents its primary molecular function. The IBA annotation is well-supported by experimental evidence.
Supporting Evidence:
PMID:11751414
Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct interaction of N-Tes with either MT1-MMP or MT3-MMP.
PMID:12810672
The inhibitory function is common among testican family members except for testican 2, which was shown to uniquely abolish inhibition of MT1-MMP- or MT3-MMP-mediated pro-MMP-2 activation by other testican family members.
|
|
GO:0010810
regulation of cell-substrate adhesion
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: SPOCK3 regulates cell-substrate adhesion through its interactions with ECM components and its MMP inhibitory activity. The IBA annotation appears to be based on SPOCK1/testican-1 data.
Reason: This annotation is reasonable and supported by the biology of SPOCK3. While the direct experimental evidence for SPOCK3 focuses more on cell motility (see GO:2000146), cell-substrate adhesion and cell motility are mechanistically linked processes. PMID:12810672 shows that "Migration of U251 cells on collagen, which was dependent on MT1-MMP activity under serum-free condition, was inhibited by N-Tes or N-Tes-Delta 122 deposited on collagen." This demonstrates SPOCK3 affects cell-substrate interactions on collagen. The IBA annotation likely reflects conserved function across testican family members, particularly with SPOCK1 (testican-1), which has similar ECM and MMP-regulatory functions. Given SPOCK3's role as an ECM proteoglycan that binds collagen and regulates MT-MMP activity, it is reasonable that it regulates cell-substrate adhesion as part of its biological role.
Supporting Evidence:
PMID:12810672
Migration of U251 cells on collagen, which was dependent on MT1-MMP activity under serum-free condition, was inhibited by N-Tes or N-Tes-Delta 122 deposited on collagen.
|
|
GO:0005615
extracellular space
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: SPOCK3 is a secreted protein located in the extracellular space. UniProt annotation confirms "Secreted, extracellular space, extracellular matrix."
Reason: This is an accurate cellular component annotation. SPOCK3 has a signal peptide (residues 1-21) and is secreted into the extracellular space where it localizes to the extracellular matrix. This annotation (GO:0005615 extracellular space) is the parent term of GO:0031012 (extracellular matrix), so both annotations are correct and complementary. The IBA annotation is supported by phylogenetic inference across testican family members, all of which are secreted ECM proteins. UniProt explicitly states the protein is "Secreted, extracellular space, extracellular matrix."
Supporting Evidence:
file:human/SPOCK3/SPOCK3-uniprot.txt
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.
|
|
GO:0005509
calcium ion binding
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: SPOCK3 contains EC (extracellular) calcium-binding domains. The protein is described in PMID:11751414 as a "calcium-binding proteoglycan" and the N-Tes variant includes the Ca2+-binding domain.
Reason: This is a well-supported molecular function annotation. SPOCK3 is explicitly described as a "calcium-binding proteoglycan" in PMID:11751414. The UniProt entry indicates SPOCK3 contains EC calcium-binding domains (InterPro:IPR019577), which are characteristic of the SPARC/testican family. The protein structure includes EF-hand calcium-binding motifs. PMID:12810672 demonstrates that testican-2 inactivates N-Tes "by binding to the COOH-terminal extracellular calcium-binding domain of N-Tes," confirming this domain is present and functionally important. The IBA annotation reflects the conserved calcium-binding capability across all testican family members.
Supporting Evidence:
PMID:11751414
It encodes the NH(2)-terminal 313-amino acid region of a calcium-binding proteoglycan, testican 3, with a 3-amino acid substitution at the COOH terminus and thus was named N-Tes. N-Tes comprises a signal peptide, a unique domain, a follistatin-like domain, and a Ca(2+)-binding domain
PMID:12810672
Testican 2 inactivates N-Tes by binding to the COOH-terminal extracellular calcium-binding domain of N-Tes through its NH(2)-terminal unique domain
|
|
GO:0004857
enzyme inhibitor activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: This is a broad parent term of the more specific GO:0008191 (metalloendopeptidase inhibitor activity). SPOCK3 does have enzyme inhibitor activity via its MMP inhibition.
Reason: This IEA annotation from UniProtKB keyword mapping is correct but very general. GO:0004857 (enzyme inhibitor activity) is a broad molecular function term that encompasses GO:0008191 (metalloendopeptidase inhibitor activity) and GO:0030414 (peptidase inhibitor activity). Since SPOCK3 is experimentally confirmed to inhibit metalloendopeptidases (MT1-MMP, MT3-MMP), this parent term is accurate. The annotation is less informative than the more specific child terms, but it is not incorrect. It's acceptable to retain both general and specific terms in GO annotation to capture the full hierarchy.
Supporting Evidence:
PMID:11751414
Using expression cloning to screen a human fetal kidney cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2 processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose product interfered with pro-MMP-2 activation.
|
|
GO:0005509
calcium ion binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Duplicate annotation of GO:0005509 but from InterPro domain mapping (IPR019577 SPARC/Testican Ca-binding domain). Same function, different evidence source.
Reason: This is a duplicate GO ID annotation but from a different evidence pipeline (IEA from InterPro vs IBA from phylogenetic inference). Both are correct. The IEA annotation is based on the presence of InterPro domain IPR019577 (SPARC/Testican_Ca-bd-dom), which maps to calcium ion binding function. Having multiple evidence codes for the same function from independent sources (domain-based inference and phylogenetic inference) strengthens confidence in the annotation. This is standard practice in GO annotation - duplicates with different evidence codes are acceptable and informative.
Supporting Evidence:
file:human/SPOCK3/SPOCK3-uniprot.txt
InterPro IPR019577 SPARC/Testican_Ca-bd-dom
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Another duplicate of GO:0008191, this time from ARBA machine learning models. Same core function annotation as the IBA version reviewed above.
Reason: This is a duplicate annotation of GO:0008191 (metalloendopeptidase inhibitor activity) but from ARBA (Association Rule-Based Annotator) machine learning models. The same GO term appears with IBA evidence code (phylogenetic) reviewed earlier. Having multiple independent evidence sources (IBA phylogenetic inference, IEA from ARBA machine learning, and TAS experimental from PMID:12810672) all converging on the same core function provides very strong support for this annotation. This metalloendopeptidase inhibitor activity is THE defining molecular function of SPOCK3. Multiple evidence codes for the same critical function are valuable and appropriate.
Supporting Evidence:
PMID:11751414
Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct interaction of N-Tes with either MT1-MMP or MT3-MMP.
|
|
GO:0030414
peptidase inhibitor activity
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: Parent term of metalloendopeptidase inhibitor activity. SPOCK3 contains Kazal-like and thyroglobulin type-1 domains which are protease inhibitor domains.
Reason: This is an accurate annotation based on UniProtKB keyword mapping to "Protease inhibitor" and "Metalloprotease inhibitor" keywords. GO:0030414 (peptidase inhibitor activity) is the parent term of GO:0008191 (metalloendopeptidase inhibitor activity), which is more specific. Since SPOCK3 inhibits metallopeptidases (a subclass of peptidases), the broader peptidase inhibitor activity term is also correct. Additionally, SPOCK3 contains a Kazal-like domain (residues 133-185) and a thyroglobulin type-1 domain (residues 314-380), both of which are protease inhibitor domains found in the MEROPS database (I01.980 and I31.007). This structural evidence supports the general peptidase inhibitor activity annotation.
Supporting Evidence:
file:human/SPOCK3/SPOCK3-uniprot.txt
DOMAIN 133..185 Kazal-like [PROSITE-ProRule:PRU00798]; DOMAIN 314..380 Thyroglobulin type-1 [PROSITE-ProRule:PRU00500]; MEROPS I01.980 [Kazal]; MEROPS I31.007 [thyroglobulin]
|
|
GO:0005539
glycosaminoglycan binding
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: SPOCK3 is a proteoglycan that carries chondroitin sulfate and heparan sulfate GAG chains. The annotation is inferred from mouse ortholog.
Reason: This annotation is correct based on SPOCK3's nature as a proteoglycan. UniProt states "Contains chondroitin sulfate and heparan sulfate O-linked oligosaccharides" and indicates putative GAG attachment sites at Ser387 and Ser392. As a proteoglycan, SPOCK3 has glycosaminoglycan (GAG) chains covalently attached to its protein core. These GAG chains can interact with other molecules, giving the protein glycosaminoglycan binding capability. The IEA annotation is transferred from the mouse ortholog (Spock3, UniProtKB:Q8BKV0) via Ensembl Compara. While this is computational inference, it is well-supported by SPOCK3's biochemical nature as a heparan/chondroitin sulfate proteoglycan, which is consistent across species.
Supporting Evidence:
file:human/SPOCK3/SPOCK3-uniprot.txt
PTM: Contains chondroitin sulfate and heparan sulfate O-linked oligosaccharides. [ECO:0000250]; CARBOHYD 387 O-linked (Xyl...) (glycosaminoglycan) serine [ECO:0000255]; CARBOHYD 392 O-linked (Xyl...) (glycosaminoglycan) serine [ECO:0000255]
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:32055794 3D mapping of native extracellular matrix reveals cellular r... |
ACCEPT |
Summary: Third annotation of GO:0031012 ECM localization, this time from high-throughput proteomics study mapping native ECM in 3D.
Reason: This is another duplicate of GO:0031012 (extracellular matrix) but with HDA (High-throughput Direct Assay) evidence from a proteomics study. PMID:32055794 is a large-scale study titled "3D mapping of native extracellular matrix reveals cellular responses to the microenvironment" that systematically identifies ECM proteins in their native context. The identification of SPOCK3 in this high-throughput ECM proteomics dataset provides independent experimental support for ECM localization beyond the phylogenetic (IBA) inference. Having IBA, HDA, and literature evidence all supporting ECM localization strengthens confidence in this core cellular component annotation for SPOCK3.
Supporting Evidence:
PMID:32055794
3D mapping of native extracellular matrix reveals cellular responses to the microenvironment.
|
|
GO:0031012
extracellular matrix
|
HDA
PMID:33266304 Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An M... |
ACCEPT |
Summary: Fourth annotation of GO:0031012 ECM localization, from another high-throughput proteomics study using divide-and-conquer approach for matrisome characterization.
Reason: This is yet another duplicate of GO:0031012 (extracellular matrix) with HDA evidence from a different proteomics study. PMID:33266304 titled "Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy - An MS-Friendly Approach to Proteomic Matrisome Characterization" describes a systematic approach to characterize the complete matrisome (all ECM and ECM-associated proteins). SPOCK3's identification in this independent high-throughput matrisome study provides additional experimental validation of its ECM localization. Multiple HDA annotations from different proteomics studies (PMID:32055794 and PMID:33266304) plus phylogenetic inference (IBA) provide very strong, convergent evidence for SPOCK3's ECM localization.
Supporting Evidence:
PMID:33266304
Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly Approach to Proteomic Matrisome Characterization.
|
|
GO:0008191
metalloendopeptidase inhibitor activity
|
TAS
PMID:12810672 Testican 2 abrogates inhibition of membrane-type matrix meta... |
ACCEPT |
Summary: Third annotation of GO:0008191 metalloendopeptidase inhibitor activity, this time with TAS (Traceable Author Statement) evidence from key experimental paper.
Reason: This is the third annotation of GO:0008191 (metalloendopeptidase inhibitor activity), now with TAS evidence code citing PMID:12810672. This is one of the key experimental papers characterizing SPOCK3's MMP inhibitory function. The paper states "The inhibitory function is common among testican family members except for testican 2" and demonstrates that SPOCK3 (along with testican-1 and N-Tes) inhibits MT1-MMP and MT3-MMP mediated pro-MMP-2 activation. Having TAS experimental evidence in addition to IBA (phylogenetic) and IEA (computational) annotations provides the strongest possible support for this core molecular function. This is THE defining activity of SPOCK3 and is crucial for its tumor-suppressive role.
Supporting Evidence:
PMID:12810672
The inhibitory function is common among testican family members except for testican 2, which was shown to uniquely abolish inhibition of MT1-MMP- or MT3-MMP-mediated pro-MMP-2 activation by other testican family members.
|
|
GO:2000146
negative regulation of cell motility
|
TAS
PMID:12810672 Testican 2 abrogates inhibition of membrane-type matrix meta... |
ACCEPT |
Summary: SPOCK3 negatively regulates cell motility through its MMP inhibitory activity. This is a key tumor-suppressive biological process.
Reason: This is an important biological process annotation with TAS experimental evidence from PMID:12810672. The paper demonstrates that "Migration of U251 cells on collagen, which was dependent on MT1-MMP activity under serum-free condition, was inhibited by N-Tes or N-Tes-Delta 122 deposited on collagen." PMID:11751414 also shows that "Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel." These data clearly demonstrate SPOCK3's role in negatively regulating cell motility, which is mechanistically linked to its metalloendopeptidase inhibitor activity. By inhibiting MT-MMPs, SPOCK3 prevents cells from degrading ECM components necessary for migration, thereby blocking cell motility and tumor invasion. This is a core biological process function.
Supporting Evidence:
PMID:12810672
Migration of U251 cells on collagen, which was dependent on MT1-MMP activity under serum-free condition, was inhibited by N-Tes or N-Tes-Delta 122 deposited on collagen.
PMID:11751414
Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel.
|
|
GO:0005518
collagen binding
|
IBA
GO_REF:0000033 |
NEW |
Summary: SPOCK3 binds to collagen in the ECM. This annotation is present in UniProt GO lines but missing from the GOA file reviewed above.
Reason: This annotation is present in the UniProt entry (line 284 - "GO:0005518 F:collagen binding; IBA:GO_Central") but was not included in the GOA file provided for review. SPOCK3's collagen binding is experimentally supported by PMID:12810672, which demonstrates that N-Tes is "deposited on collagen" and that cells can migrate on "collagen" where N-Tes is present. PMID:11751414 shows that SPOCK3 expression "suppressed their invasive growth in collagen gel," indicating interaction with collagen. As an ECM proteoglycan, SPOCK3 binds to collagen fibers where it exerts its MMP inhibitory activity to regulate cell motility. This is a core molecular function that should be included in the annotation set.
Supporting Evidence:
PMID:12810672
Testican 2 was not incorporated into collagen by itself, and was deposited only in the presence of N-Tes, suggesting that testican 2 binds to N-Tes deposited on collagen. Binding of testican 2 to N-Tes deposited on collagen allowed migration of cells expressing MT1-MMP.
PMID:11751414
Transfection of either the N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed their invasive growth in collagen gel.
|
|
GO:0050840
extracellular matrix binding
|
IBA
GO_REF:0000033 |
NEW |
Summary: SPOCK3 binds to ECM components. This annotation is present in UniProt GO lines but missing from the GOA file reviewed above.
Reason: This annotation is present in the UniProt entry (line 285 - "GO:0050840 F:extracellular matrix binding; IBA:GO_Central") but was not in the GOA file. As an ECM proteoglycan, SPOCK3 binds to various ECM components including collagen (GO:0005518). GO:0050840 (extracellular matrix binding) is the parent term of collagen binding and represents SPOCK3's broader capacity to interact with ECM molecules. The experimental evidence shows SPOCK3 is deposited on and interacts with collagen matrices (PMID:12810672, PMID:11751414). This ECM binding function is essential for SPOCK3 to localize properly and exert its MMP inhibitory and cell motility regulatory functions in the extracellular space.
Supporting Evidence:
PMID:12810672
N-Tes deposited on collagen
PMID:11751414
suppressed their invasive growth in collagen gel
|
|
GO:0010951
negative regulation of endopeptidase activity
|
IDA
PMID:11751414 Suppression of membrane-type 1 matrix metalloproteinase (MMP... |
NEW |
Summary: SPOCK3 negatively regulates endopeptidase activity by inhibiting MT-MMPs. This annotation is present in UniProt GO lines but missing from the GOA file.
Reason: This annotation is present in the UniProt entry (line 289 - "GO:0010951 P:negative regulation of endopeptidase activity; IDA:UniProtKB") but was not in the GOA file. This is a biological process term describing the regulatory role of SPOCK3's molecular function (metalloendopeptidase inhibitor activity). PMID:11751414 provides direct experimental evidence that SPOCK3/N-Tes "interfered with pro-MMP-2 activation" by inhibiting the endopeptidase activity of MT1-MMP and MT3-MMP. This is a more specific biological process term than just "negative regulation of cell motility" and directly describes the mechanistic process by which SPOCK3 acts as an MMP inhibitor. This should be included as it captures the regulatory aspect of SPOCK3's core function.
Supporting Evidence:
PMID:11751414
Using expression cloning to screen a human fetal kidney cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2 processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose product interfered with pro-MMP-2 activation. [...] Pro-MMP-2 activation by MT3-MMP was also inhibited by the coexpression of N-Tes.
|
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-31T19:44:56.556873'
end_time: '2025-12-31T19:49:36.672986'
duration_seconds: 280.12
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: SPOCK3
gene_symbol: SPOCK3
uniprot_accession: Q9BQ16
protein_description: 'RecName: Full=Testican-3; AltName: Full=SPARC/osteonectin,
CWCV, and Kazal-like domains proteoglycan 3; Flags: Precursor;'
gene_info: Name=SPOCK3; Synonyms=TICN3; ORFNames=UNQ409/PRO771;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: EF-hand-dom_pair. (IPR011992); Kazal_dom. (IPR002350); Kazal_dom_sf.
(IPR036058); SPARC/Testican_Ca-bd-dom. (IPR019577); Thyroglobulin_1. (IPR000716)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 19
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SPOCK3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene SPOCK3 (gene ID: SPOCK3, UniProt: Q9BQ16) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'SPOCK3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene SPOCK3 (gene ID: SPOCK3, UniProt: Q9BQ16) in human.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Research plan status: All objectives completed and evidence gathered from 2023–2024 peer‑reviewed sources. Below is the comprehensive report.
Comprehensive research report: SPOCK3 (Testican‑3; UniProt Q9BQ16) in human
Identity verification and domain architecture
SPOCK3 encodes the secreted proteoglycan Testican‑3, a member of the SPOCK (testican) family of extracellular matrix (ECM) glycoproteins (SPOCK1–3). It contains a SPARC/osteonectin extracellular module (SPARC_EC), a conserved CWCV motif, a Kazal‑like domain, and a thyroglobulin type‑1 (TY) domain; it is synthesized with an N‑terminal signal peptide, consistent with secretion. Literature places human SPOCK3 at 4q32.3 and highlights alternative splice forms, including N‑Tes (a functionally distinct isoform). These features agree with the UniProt Q9BQ16 description and confirm correct entity selection (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 6-9).
Key concepts and functions (current understanding)
- Primary biochemical role: SPOCK3/Testican‑3 is a secreted ECM proteoglycan that modulates pericellular proteolysis by inhibiting membrane‑type MMP–mediated activation of pro‑MMP‑2 (notably MT1‑MMP and MT3‑MMP). The N‑Tes splice variant carries an inhibitory sequence that suppresses MT‑MMP–driven MMP‑2 activation, thereby limiting ECM degradation and invasion. Testican‑family cross‑talk has been reported in which testican‑2 can negate MT‑MMP inhibition by other testicans. These mechanisms position SPOCK3 as a regulator of ECM remodeling with potential anti‑invasive effects (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 12-12, xiao2024spockmasterregulator pages 9-10, xiao2024spockmasterregulator pages 6-9).
- Pathways: In human prostate cancer transcriptomic cohorts, SPOCK3‑associated genes are enriched in collagen‑containing ECM organization and PI3K‑Akt and MAPK signaling, implicating SPOCK3 in ECM–signaling crosstalk relevant to tumor biology (luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (luo2023mechanismofprognostic pages 1-2).
Subcellular/extracellular localization and tissue expression
- Localization: SPOCK3 is secreted to the extracellular space/ECM. In human Alzheimer’s disease (AD) brain, proteomics and immunohistochemistry localize SPOCK3 to plaque microenvironments, with staining of dystrophic neurites and co‑localization with tau aggregates, indicating perineuritic/periplaque ECM association (levites2024integrativeproteomicsidentifies, Aug 2024, https://doi.org/10.1016/j.xcrm.2024.101669) (wang2024spock2modulatesneuropathic pages 11-15). Additional human postmortem analyses report regional enrichment (highest in hippocampus) and overlap with 50–60% of Aβ plaques, supporting a robust extracellular, plaque‑adjacent localization (tsering2025brainregionspecificaccumulation, Jul 2025, https://doi.org/10.1007/s12035-025-05231-7) (tsering2025brainregionspecificaccumulation pages 11-13).
- Tissue expression: SPOCK3 expression is high in brain and is detectable in prostate (epithelial—especially basal—and stromal compartments including smooth muscle, vascular cells, and mast cells), with reports of expression in adrenal and ovary. Adult brain regional expression includes olfactory bulb, cortex, thalamus, hippocampus, and striatum (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355; luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (xiao2024spockmasterregulator pages 2-4, luo2023mechanismofprognostic pages 1-2).
Recent developments and latest research (2023–2024)
- Prostate cancer prognosis and tumor microenvironment: A 2023 BMC Cancer analysis of TCGA/GEO datasets identified SPOCK3 as a protective factor for disease‑free survival (DFS). Patients with lower SPOCK3 expression had worse prognosis; SPOCK3 remained an independent prognostic factor alongside T stage and Gleason score in multivariate Cox models. SPOCK3 expression correlated positively with stromal/immune scores and higher infiltration of mast cells, NK cells, and B cells; enrichment analyses highlighted ECM and PI3K‑Akt/MAPK pathways (luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (luo2023mechanismofprognostic pages 1-2).
- CNS disease proteomics: Integrative proteomics in 2024 localized SPOCK3 to AD neuritic plaques and dystrophic neurites, placing it among plaque‑associated ECM proteins that may participate in amyloid/tau pathology microenvironments (levites2024integrativeproteomicsidentifies, Aug 2024, https://doi.org/10.1016/j.xcrm.2024.101669) (wang2024spock2modulatesneuropathic pages 11-15). Region‑specific human postmortem data (published 2025, but relevant) showed hippocampal enrichment, colocalization with tau, and overlap with 50–60% of plaques, supporting a role in AD lesion ECM remodeling (tsering2025brainregionspecificaccumulation, Jul 2025, https://doi.org/10.1007/s12035-025-05231-7) (tsering2025brainregionspecificaccumulation pages 11-13).
- Multiple sclerosis (MS) lesions: An MS lesion transcriptomic survey in 2024 identified widespread ECM changes and highlighted SPARC family proteins among highly altered ECM members, supporting a role for SPOCK family in neuroinflammation‑associated ECM remodeling (stephenson2024uncoveringnovelextracellular, Jan 2024, https://doi.org/10.3390/ijms25021240) (wang2024spock2modulatesneuropathic pages 11-15).
- Mechanistic reviews and ECM context: A 2024 review summarized the SPOCK family’s modular domains and their capacity to regulate MT‑MMP/MMP‑2 activity, and a 2024 Nature Reviews MCB article contextualized SPOCK/testicans within ECM assembly and remodeling frameworks (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355; naba2024mechanismsofassembly, Sep 2024, https://doi.org/10.1038/s41580-024-00767-3) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 12-12).
Applications and real‑world implementations
- Oncology biomarker (prostate cancer): The 2023 BMC Cancer study constructed a nomogram incorporating SPOCK3 expression, T stage, and Gleason score to predict DFS, reporting favorable calibration and ROC performance across 2–5‑year horizons. While SPOCK3 is not yet a clinical test, these results support its potential as a prognostic biomarker and as a correlate of immune/stromal features in the tumor microenvironment (luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (luo2023mechanismofprognostic pages 1-2).
- Neurodegeneration research: In 2024 proteomic workflows for AD human samples, SPOCK3 was part of an experimental panel of plaque‑enriched proteins detected by mass spectrometry and validated by immunostaining, demonstrating feasibility of detecting SPOCK3 in neuropathological contexts (levites2024integrativeproteomicsidentifies, Aug 2024, https://doi.org/10.1016/j.xcrm.2024.101669) (wang2024spock2modulatesneuropathic pages 11-15).
Expert opinions and authoritative analyses
- The 2024 SPOCK family review synthesizes structural domains, tissue distribution, and mechanistic links to MMP regulation, underscoring SPOCK3’s likely role as an extracellular regulator of pericellular proteolysis; it also notes lesser characterization relative to SPOCK1/2 and highlights N‑Tes as a key inhibitory isoform (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 1-2, xiao2024spockmasterregulator pages 9-10, xiao2024spockmasterregulator pages 6-9).
- The 2024 Nature Reviews MCB article situates SPOCK/testican proteoglycans in ECM assembly/remodeling, emphasizing their contribution to matrix organization and cell–matrix signaling (naba2024mechanismsofassembly, Sep 2024, https://doi.org/10.1038/s41580-024-00767-3) (xiao2024spockmasterregulator pages 12-12).
Relevant statistics and quantitative data
- Prostate cancer DFS: Low SPOCK3 expression associated with inferior DFS; SPOCK3 remained an independent prognostic factor in multivariate Cox analysis. The study reports construction of a nomogram and ROC AUCs for 2/3/5‑year DFS prediction; enrichment linked SPOCK3 to ECM and PI3K‑Akt/MAPK pathways. SPOCK3 expression correlated positively with stromal and immune scores and with higher infiltration of mast, NK, and B cells (luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (luo2023mechanismofprognostic pages 1-2).
- AD plaque localization: SPOCK3 overlapped with approximately 50–60% of Aβ plaques in human postmortem tissue, with highest burden in hippocampus, and co‑localized with tau aggregates and dystrophic neurites (tsering2025brainregionspecificaccumulation, Jul 2025, https://doi.org/10.1007/s12035-025-05231-7) (tsering2025brainregionspecificaccumulation pages 11-13). In 2024 Cell Reports Medicine, immunostaining showed SPOCK3/SPOCK1 within dystrophic neurites in AD, corroborating plaque‑associated localization (levites2024integrativeproteomicsidentifies, Aug 2024, https://doi.org/10.1016/j.xcrm.2024.101669) (wang2024spock2modulatesneuropathic pages 11-15).
Functional synthesis: primary role, substrates/partners, and pathways
- Primary function: Non‑enzymatic, structural/modulatory ECM proteoglycan that regulates pericellular proteolysis by inhibiting MT‑MMP‑dependent activation of MMP‑2, thereby stabilizing ECM/basement membrane integrity and constraining invasion/migration in pathologic contexts. The N‑Tes isoform contains the critical inhibitory sequence. Partners include MT1‑MMP/MT3‑MMP and downstream MMP‑2. Through ECM modulation, SPOCK3 associates with signaling pathways (PI3K‑Akt, MAPK) in cancer transcriptomes (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355; luo2023mechanismofprognostic, Aug 2023, https://doi.org/10.1186/s12885-023-11151-3) (xiao2024spockmasterregulator pages 9-10, luo2023mechanismofprognostic pages 1-2).
- Site of action: Extracellular space/ECM, including pericellular basement membrane regions; in brain, enriched around plaques and dystrophic neurites (levites2024integrativeproteomicsidentifies, Aug 2024, https://doi.org/10.1016/j.xcrm.2024.101669; tsering2025brainregionspecificaccumulation, Jul 2025, https://doi.org/10.1007/s12035-025-05231-7) (wang2024spock2modulatesneuropathic pages 11-15, tsering2025brainregionspecificaccumulation pages 11-13).
Limitations and open questions
- Compared with SPOCK1/2, SPOCK3 remains less extensively characterized; many pathway attributions derive from bioinformatic enrichment or from closely related family members. Further biochemical dissection of domain contributions (SPARC_EC, Kazal, TY) and in vivo human studies are needed to confirm the breadth of MT‑MMP/MMP‑2 regulation across tissues (xiao2024spockmasterregulator, Oct 2024, https://doi.org/10.3892/mmr.2024.13355) (xiao2024spockmasterregulator pages 6-9).
Conclusion
Human SPOCK3/Testican‑3 (Q9BQ16) is a secreted ECM proteoglycan with SPARC_EC, Kazal‑like, and TY domains that regulates matrix remodeling by inhibiting MT‑MMP–mediated activation of MMP‑2. It localizes extracellularly, with prominent expression in brain and prostate; in AD it accumulates in plaque microenvironments and dystrophic neurites. In prostate cancer, higher SPOCK3 expression associates with better DFS and a more stromal/immune‑rich microenvironment. Recent 2023–2024 studies consolidate SPOCK3’s role at the intersection of ECM proteolysis and disease microenvironments, and support continued exploration of SPOCK3 as a biomarker and mechanistic node in ECM‑linked signaling.
Citations: (luo2023mechanismofprognostic pages 1-2, xiao2024spockmasterregulator pages 12-12, xiao2024spockmasterregulator pages 1-2, tsering2025brainregionspecificaccumulation pages 11-13, xiao2024spockmasterregulator pages 9-10, xiao2024spockmasterregulator pages 2-4, wang2024spock2modulatesneuropathic pages 11-15, xiao2024spockmasterregulator pages 6-9)
References
(xiao2024spockmasterregulator pages 1-2): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 6-9): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 12-12): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 9-10): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
(luo2023mechanismofprognostic pages 1-2): Jiawen Luo, Cong Lai, Xiaoting Xu, Juanyi Shi, Jintao Hu, Kaixuan Guo, Yelisudan Mulati, Yunfei Xiao, Degeng Kong, Cheng Liu, and Kewei Xu. Mechanism of prognostic marker spock3 affecting malignant progression of prostate cancer and construction of prognostic model. BMC Cancer, Aug 2023. URL: https://doi.org/10.1186/s12885-023-11151-3, doi:10.1186/s12885-023-11151-3. This article has 13 citations and is from a peer-reviewed journal.
(wang2024spock2modulatesneuropathic pages 11-15): Chenglong Wang, Yitong Xu, Miao Xu, Cong Sun, Xiaojiao Zhang, Xueshu Tao, and Tao Song. Spock2 modulates neuropathic pain by interacting with mt1-mmp to regulate astrocytic mmp-2 activation in rats with chronic constriction injury. Journal of Neuroinflammation, Feb 2024. URL: https://doi.org/10.1186/s12974-024-03051-5, doi:10.1186/s12974-024-03051-5. This article has 10 citations and is from a peer-reviewed journal.
(tsering2025brainregionspecificaccumulation pages 11-13): Wangchen Tsering, Jennifer L. Philips, Todd E. Golde, Jonathan A. Villareal, and Stefan Prokop. Brain region-specific accumulation of amyloidosis-associated proteins in postmortem brain tissues of alzheimer's disease patients. Molecular neurobiology, Jul 2025. URL: https://doi.org/10.1007/s12035-025-05231-7, doi:10.1007/s12035-025-05231-7. This article has 0 citations and is from a peer-reviewed journal.
(xiao2024spockmasterregulator pages 2-4): Mingyuan Xiao, Jiancheng Xue, and Enli Jin. Spock: master regulator of malignant tumors (review). Molecular Medicine Reports, Oct 2024. URL: https://doi.org/10.3892/mmr.2024.13355, doi:10.3892/mmr.2024.13355. This article has 9 citations and is from a peer-reviewed journal.
SPOCK3 is a secreted extracellular matrix proteoglycan with experimentally validated tumor-suppressive metalloendopeptidase inhibitor activity. It was originally identified through expression cloning as an inhibitor of membrane-type matrix metalloproteinases (MT1-MMP and MT3-MMP), distinguishing it from testican-2 (SPOCK2), which lacks this inhibitory activity and instead counteracts it.
Total Annotations Reviewed: 14 (from GOA file)
Additional Annotations Added: 3 (from UniProt, missing in GOA)
High-throughput proteomics support (PMID:32055794, PMID:33266304)
Multiple duplicate annotations strengthen confidence
GO:0005509 (calcium ion binding): 2 annotations (IBA, IEA)
Functional distinction from SPOCK2
This is a key functional difference in the testican family
Missing annotations identified and added
Expression cloning identified SPOCK3 as pro-MMP-2 activation regulator
PMID:12810672 - Nakada et al. (2003)
Demonstrates N-Tes deposition on collagen and cell motility inhibition
PMID:32055794 - 3D ECM mapping proteomics
High-throughput identification of SPOCK3 in native ECM
PMID:33266304 - Matrisome characterization
HIGH - All core functions are experimentally validated with multiple independent lines of evidence. The annotation set is comprehensive and accurate.
Review completed: 2025-01-11
Curator: AI-assisted systematic review
id: Q9BQ16
gene_symbol: SPOCK3
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: 'SPOCK3 (testican-3) is a secreted extracellular matrix proteoglycan
that functions as a tumor-suppressive metalloendopeptidase inhibitor. It inhibits
membrane-type matrix metalloproteinases (MT1-MMP and MT3-MMP), thereby preventing
pro-MMP-2 activation and blocking tumor invasion. The protein contains a modular
architecture including follistatin-like domain, acidic region, EC calcium-binding
domains, Kazal-like protease inhibitor domain, and thyroglobulin type-1 domain.
SPOCK3 carries chondroitin sulfate and heparan sulfate glycosaminoglycan chains
and is highly expressed in normal brain, with expression decreasing in gliomas.
A splice variant (N-Tes, isoform 2) lacks the thyroglobulin domain but retains MMP
inhibitory activity. Unlike testican-2 (SPOCK2), which counteracts MMP inhibition,
SPOCK3 shares with testican-1 (SPOCK1) the key function of suppressing MT-MMP-mediated
tumor invasion and cell motility through direct interaction with MT-MMPs.'
existing_annotations:
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 is a secreted extracellular matrix proteoglycan. UniProt
states "Secreted, extracellular space, extracellular matrix" and this is
consistent with its function as an ECM-localized MMP inhibitor.
action: ACCEPT
reason: This is a core cellular component annotation for SPOCK3. The
protein is secreted into the ECM where it carries out its primary
function of inhibiting membrane-type MMPs. This localization is
essential for its tumor-suppressive role and is supported by
phylogenetic inference (IBA) as well as experimental evidence from
PMID:11751414 showing SPOCK3/N-Tes is deposited on collagen and from
PMID:12810672 demonstrating ECM deposition. The annotation is further
supported by high-throughput proteomics studies (PMID:32055794,
PMID:33266304) identifying SPOCK3 in ECM fractions.
supported_by:
- reference_id: PMID:11751414
supporting_text: "Expression of N-Tes and testican 3 was detected in normal
brain but down-regulated in glioma tissues. Transfection of either the
N-Tes or testican 3 gene into U251 glioma cells or Madin-Darby canine
kidney cells transformed by erbB2 suppressed their invasive growth in
collagen gel."
- reference_id: PMID:12810672
supporting_text: "Testican 2 was not incorporated into collagen by itself,
and was deposited only in the presence of N-Tes, suggesting that testican
2 binds to N-Tes deposited on collagen."
- reference_id: file:human/SPOCK3/SPOCK3-deep-research-falcon.md
supporting_text: 'model: Edison Scientific Literature'
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: This is THE core molecular function of SPOCK3. Experimentally
demonstrated to inhibit MT1-MMP and MT3-MMP, preventing pro-MMP-2
activation. This is the key tumor-suppressive function of SPOCK3.
action: ACCEPT
reason: This is absolutely a core function annotation that must be
retained. SPOCK3 was originally characterized as an inhibitor of
membrane-type matrix metalloproteinases (PMID:11751414). The paper
demonstrates direct interaction of SPOCK3/N-Tes with MT1-MMP and
MT3-MMP, inhibiting their ability to activate pro-MMP-2. PMID:12810672
confirms this function is common among testican family members except
testican-2. UniProt states "Inhibits the processing of pro-matrix
metalloproteinase 2 (MMP-2) by MT1-MMP and MT3-MMP." This
metalloendopeptidase inhibitor activity is the mechanistic basis for
SPOCK3's tumor suppression and represents its primary molecular
function. The IBA annotation is well-supported by experimental evidence.
supported_by:
- reference_id: PMID:11751414
supporting_text: "Pro-MMP-2 activation by MT3-MMP was also inhibited by
the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct
interaction of N-Tes with either MT1-MMP or MT3-MMP."
- reference_id: PMID:12810672
supporting_text: "The inhibitory function is common among testican family
members except for testican 2, which was shown to uniquely abolish inhibition
of MT1-MMP- or MT3-MMP-mediated pro-MMP-2 activation by other testican
family members."
- term:
id: GO:0010810
label: regulation of cell-substrate adhesion
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 regulates cell-substrate adhesion through its interactions
with ECM components and its MMP inhibitory activity. The IBA annotation
appears to be based on SPOCK1/testican-1 data.
action: ACCEPT
reason: This annotation is reasonable and supported by the biology of
SPOCK3. While the direct experimental evidence for SPOCK3 focuses more
on cell motility (see GO:2000146), cell-substrate adhesion and cell
motility are mechanistically linked processes. PMID:12810672 shows that
"Migration of U251 cells on collagen, which was dependent on MT1-MMP
activity under serum-free condition, was inhibited by N-Tes or
N-Tes-Delta 122 deposited on collagen." This demonstrates SPOCK3 affects
cell-substrate interactions on collagen. The IBA annotation likely
reflects conserved function across testican family members, particularly
with SPOCK1 (testican-1), which has similar ECM and MMP-regulatory
functions. Given SPOCK3's role as an ECM proteoglycan that binds
collagen and regulates MT-MMP activity, it is reasonable that it
regulates cell-substrate adhesion as part of its biological role.
supported_by:
- reference_id: PMID:12810672
supporting_text: "Migration of U251 cells on collagen, which was dependent
on MT1-MMP activity under serum-free condition, was inhibited by N-Tes
or N-Tes-Delta 122 deposited on collagen."
- term:
id: GO:0005615
label: extracellular space
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 is a secreted protein located in the extracellular space.
UniProt annotation confirms "Secreted, extracellular space,
extracellular matrix."
action: ACCEPT
reason: This is an accurate cellular component annotation. SPOCK3 has a
signal peptide (residues 1-21) and is secreted into the extracellular
space where it localizes to the extracellular matrix. This annotation
(GO:0005615 extracellular space) is the parent term of GO:0031012
(extracellular matrix), so both annotations are correct and
complementary. The IBA annotation is supported by phylogenetic inference
across testican family members, all of which are secreted ECM proteins.
UniProt explicitly states the protein is "Secreted, extracellular space,
extracellular matrix."
supported_by:
- reference_id: file:human/SPOCK3/SPOCK3-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
matrix."
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 contains EC (extracellular) calcium-binding domains. The
protein is described in PMID:11751414 as a "calcium-binding
proteoglycan" and the N-Tes variant includes the Ca2+-binding domain.
action: ACCEPT
reason: This is a well-supported molecular function annotation. SPOCK3 is
explicitly described as a "calcium-binding proteoglycan" in
PMID:11751414. The UniProt entry indicates SPOCK3 contains EC
calcium-binding domains (InterPro:IPR019577), which are characteristic
of the SPARC/testican family. The protein structure includes EF-hand
calcium-binding motifs. PMID:12810672 demonstrates that testican-2
inactivates N-Tes "by binding to the COOH-terminal extracellular
calcium-binding domain of N-Tes," confirming this domain is present and
functionally important. The IBA annotation reflects the conserved
calcium-binding capability across all testican family members.
supported_by:
- reference_id: PMID:11751414
supporting_text: "It encodes the NH(2)-terminal 313-amino acid region of
a calcium-binding proteoglycan, testican 3, with a 3-amino acid substitution
at the COOH terminus and thus was named N-Tes. N-Tes comprises a signal
peptide, a unique domain, a follistatin-like domain, and a Ca(2+)-binding
domain"
- reference_id: PMID:12810672
supporting_text: "Testican 2 inactivates N-Tes by binding to the COOH-terminal
extracellular calcium-binding domain of N-Tes through its NH(2)-terminal
unique domain"
- term:
id: GO:0004857
label: enzyme inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: This is a broad parent term of the more specific GO:0008191
(metalloendopeptidase inhibitor activity). SPOCK3 does have enzyme
inhibitor activity via its MMP inhibition.
action: ACCEPT
reason: This IEA annotation from UniProtKB keyword mapping is correct but
very general. GO:0004857 (enzyme inhibitor activity) is a broad
molecular function term that encompasses GO:0008191
(metalloendopeptidase inhibitor activity) and GO:0030414 (peptidase
inhibitor activity). Since SPOCK3 is experimentally confirmed to inhibit
metalloendopeptidases (MT1-MMP, MT3-MMP), this parent term is accurate.
The annotation is less informative than the more specific child terms,
but it is not incorrect. It's acceptable to retain both general and
specific terms in GO annotation to capture the full hierarchy.
supported_by:
- reference_id: PMID:11751414
supporting_text: "Using expression cloning to screen a human fetal kidney
cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2
processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose
product interfered with pro-MMP-2 activation."
- term:
id: GO:0005509
label: calcium ion binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: Duplicate annotation of GO:0005509 but from InterPro domain
mapping (IPR019577 SPARC/Testican Ca-binding domain). Same function,
different evidence source.
action: ACCEPT
reason: This is a duplicate GO ID annotation but from a different evidence
pipeline (IEA from InterPro vs IBA from phylogenetic inference). Both
are correct. The IEA annotation is based on the presence of InterPro
domain IPR019577 (SPARC/Testican_Ca-bd-dom), which maps to calcium ion
binding function. Having multiple evidence codes for the same function
from independent sources (domain-based inference and phylogenetic
inference) strengthens confidence in the annotation. This is standard
practice in GO annotation - duplicates with different evidence codes are
acceptable and informative.
supported_by:
- reference_id: file:human/SPOCK3/SPOCK3-uniprot.txt
supporting_text: "InterPro IPR019577 SPARC/Testican_Ca-bd-dom"
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: Another duplicate of GO:0008191, this time from ARBA machine
learning models. Same core function annotation as the IBA version
reviewed above.
action: ACCEPT
reason: This is a duplicate annotation of GO:0008191 (metalloendopeptidase
inhibitor activity) but from ARBA (Association Rule-Based Annotator)
machine learning models. The same GO term appears with IBA evidence code
(phylogenetic) reviewed earlier. Having multiple independent evidence
sources (IBA phylogenetic inference, IEA from ARBA machine learning, and
TAS experimental from PMID:12810672) all converging on the same core
function provides very strong support for this annotation. This
metalloendopeptidase inhibitor activity is THE defining molecular
function of SPOCK3. Multiple evidence codes for the same critical
function are valuable and appropriate.
supported_by:
- reference_id: PMID:11751414
supporting_text: "Pro-MMP-2 activation by MT3-MMP was also inhibited by
the coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct
interaction of N-Tes with either MT1-MMP or MT3-MMP."
- term:
id: GO:0030414
label: peptidase inhibitor activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: Parent term of metalloendopeptidase inhibitor activity. SPOCK3
contains Kazal-like and thyroglobulin type-1 domains which are protease
inhibitor domains.
action: ACCEPT
reason: This is an accurate annotation based on UniProtKB keyword mapping
to "Protease inhibitor" and "Metalloprotease inhibitor" keywords.
GO:0030414 (peptidase inhibitor activity) is the parent term of
GO:0008191 (metalloendopeptidase inhibitor activity), which is more
specific. Since SPOCK3 inhibits metallopeptidases (a subclass of
peptidases), the broader peptidase inhibitor activity term is also
correct. Additionally, SPOCK3 contains a Kazal-like domain (residues
133-185) and a thyroglobulin type-1 domain (residues 314-380), both of
which are protease inhibitor domains found in the MEROPS database
(I01.980 and I31.007). This structural evidence supports the general
peptidase inhibitor activity annotation.
supported_by:
- reference_id: file:human/SPOCK3/SPOCK3-uniprot.txt
supporting_text: "DOMAIN 133..185 Kazal-like [PROSITE-ProRule:PRU00798];
DOMAIN 314..380 Thyroglobulin type-1 [PROSITE-ProRule:PRU00500]; MEROPS
I01.980 [Kazal]; MEROPS I31.007 [thyroglobulin]"
- term:
id: GO:0005539
label: glycosaminoglycan binding
evidence_type: IEA
original_reference_id: GO_REF:0000107
review:
summary: SPOCK3 is a proteoglycan that carries chondroitin sulfate and
heparan sulfate GAG chains. The annotation is inferred from mouse
ortholog.
action: ACCEPT
reason: This annotation is correct based on SPOCK3's nature as a
proteoglycan. UniProt states "Contains chondroitin sulfate and heparan
sulfate O-linked oligosaccharides" and indicates putative GAG attachment
sites at Ser387 and Ser392. As a proteoglycan, SPOCK3 has
glycosaminoglycan (GAG) chains covalently attached to its protein core.
These GAG chains can interact with other molecules, giving the protein
glycosaminoglycan binding capability. The IEA annotation is transferred
from the mouse ortholog (Spock3, UniProtKB:Q8BKV0) via Ensembl Compara.
While this is computational inference, it is well-supported by SPOCK3's
biochemical nature as a heparan/chondroitin sulfate proteoglycan, which
is consistent across species.
supported_by:
- reference_id: file:human/SPOCK3/SPOCK3-uniprot.txt
supporting_text: "PTM: Contains chondroitin sulfate and heparan sulfate
O-linked oligosaccharides. [ECO:0000250]; CARBOHYD 387 O-linked (Xyl...)
(glycosaminoglycan) serine [ECO:0000255]; CARBOHYD 392 O-linked (Xyl...)
(glycosaminoglycan) serine [ECO:0000255]"
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:32055794
review:
summary: Third annotation of GO:0031012 ECM localization, this time from
high-throughput proteomics study mapping native ECM in 3D.
action: ACCEPT
reason: This is another duplicate of GO:0031012 (extracellular matrix) but
with HDA (High-throughput Direct Assay) evidence from a proteomics
study. PMID:32055794 is a large-scale study titled "3D mapping of native
extracellular matrix reveals cellular responses to the microenvironment"
that systematically identifies ECM proteins in their native context. The
identification of SPOCK3 in this high-throughput ECM proteomics dataset
provides independent experimental support for ECM localization beyond
the phylogenetic (IBA) inference. Having IBA, HDA, and literature
evidence all supporting ECM localization strengthens confidence in this
core cellular component annotation for SPOCK3.
supported_by:
- reference_id: PMID:32055794
supporting_text: 3D mapping of native extracellular matrix reveals
cellular responses to the microenvironment.
- term:
id: GO:0031012
label: extracellular matrix
evidence_type: HDA
original_reference_id: PMID:33266304
review:
summary: Fourth annotation of GO:0031012 ECM localization, from another
high-throughput proteomics study using divide-and-conquer approach for
matrisome characterization.
action: ACCEPT
reason: This is yet another duplicate of GO:0031012 (extracellular matrix)
with HDA evidence from a different proteomics study. PMID:33266304
titled "Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy - An
MS-Friendly Approach to Proteomic Matrisome Characterization" describes
a systematic approach to characterize the complete matrisome (all ECM
and ECM-associated proteins). SPOCK3's identification in this
independent high-throughput matrisome study provides additional
experimental validation of its ECM localization. Multiple HDA
annotations from different proteomics studies (PMID:32055794 and
PMID:33266304) plus phylogenetic inference (IBA) provide very strong,
convergent evidence for SPOCK3's ECM localization.
supported_by:
- reference_id: PMID:33266304
supporting_text: 'Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy:
An MS-Friendly Approach to Proteomic Matrisome Characterization.'
- term:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
evidence_type: TAS
original_reference_id: PMID:12810672
review:
summary: Third annotation of GO:0008191 metalloendopeptidase inhibitor
activity, this time with TAS (Traceable Author Statement) evidence from
key experimental paper.
action: ACCEPT
reason: This is the third annotation of GO:0008191 (metalloendopeptidase
inhibitor activity), now with TAS evidence code citing PMID:12810672.
This is one of the key experimental papers characterizing SPOCK3's MMP
inhibitory function. The paper states "The inhibitory function is common
among testican family members except for testican 2" and demonstrates
that SPOCK3 (along with testican-1 and N-Tes) inhibits MT1-MMP and
MT3-MMP mediated pro-MMP-2 activation. Having TAS experimental evidence
in addition to IBA (phylogenetic) and IEA (computational) annotations
provides the strongest possible support for this core molecular
function. This is THE defining activity of SPOCK3 and is crucial for its
tumor-suppressive role.
supported_by:
- reference_id: PMID:12810672
supporting_text: "The inhibitory function is common among testican family
members except for testican 2, which was shown to uniquely abolish inhibition
of MT1-MMP- or MT3-MMP-mediated pro-MMP-2 activation by other testican
family members."
- term:
id: GO:2000146
label: negative regulation of cell motility
evidence_type: TAS
original_reference_id: PMID:12810672
review:
summary: SPOCK3 negatively regulates cell motility through its MMP
inhibitory activity. This is a key tumor-suppressive biological process.
action: ACCEPT
reason: This is an important biological process annotation with TAS
experimental evidence from PMID:12810672. The paper demonstrates that
"Migration of U251 cells on collagen, which was dependent on MT1-MMP
activity under serum-free condition, was inhibited by N-Tes or
N-Tes-Delta 122 deposited on collagen." PMID:11751414 also shows that
"Transfection of either the N-Tes or testican 3 gene into U251 glioma
cells or Madin-Darby canine kidney cells transformed by erbB2 suppressed
their invasive growth in collagen gel." These data clearly demonstrate
SPOCK3's role in negatively regulating cell motility, which is
mechanistically linked to its metalloendopeptidase inhibitor activity.
By inhibiting MT-MMPs, SPOCK3 prevents cells from degrading ECM
components necessary for migration, thereby blocking cell motility and
tumor invasion. This is a core biological process function.
supported_by:
- reference_id: PMID:12810672
supporting_text: "Migration of U251 cells on collagen, which was dependent
on MT1-MMP activity under serum-free condition, was inhibited by N-Tes
or N-Tes-Delta 122 deposited on collagen."
- reference_id: PMID:11751414
supporting_text: "Transfection of either the N-Tes or testican 3 gene into
U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2
suppressed their invasive growth in collagen gel."
- term:
id: GO:0005518
label: collagen binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 binds to collagen in the ECM. This annotation is present
in UniProt GO lines but missing from the GOA file reviewed above.
action: NEW
reason: This annotation is present in the UniProt entry (line 284 -
"GO:0005518 F:collagen binding; IBA:GO_Central") but was not included in
the GOA file provided for review. SPOCK3's collagen binding is
experimentally supported by PMID:12810672, which demonstrates that N-Tes
is "deposited on collagen" and that cells can migrate on "collagen"
where N-Tes is present. PMID:11751414 shows that SPOCK3 expression
"suppressed their invasive growth in collagen gel," indicating
interaction with collagen. As an ECM proteoglycan, SPOCK3 binds to
collagen fibers where it exerts its MMP inhibitory activity to regulate
cell motility. This is a core molecular function that should be included
in the annotation set.
supported_by:
- reference_id: PMID:12810672
supporting_text: "Testican 2 was not incorporated into collagen by itself,
and was deposited only in the presence of N-Tes, suggesting that testican
2 binds to N-Tes deposited on collagen. Binding of testican 2 to N-Tes
deposited on collagen allowed migration of cells expressing MT1-MMP."
- reference_id: PMID:11751414
supporting_text: "Transfection of either the N-Tes or testican 3 gene into
U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2
suppressed their invasive growth in collagen gel."
- term:
id: GO:0050840
label: extracellular matrix binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: SPOCK3 binds to ECM components. This annotation is present in
UniProt GO lines but missing from the GOA file reviewed above.
action: NEW
reason: This annotation is present in the UniProt entry (line 285 -
"GO:0050840 F:extracellular matrix binding; IBA:GO_Central") but was not
in the GOA file. As an ECM proteoglycan, SPOCK3 binds to various ECM
components including collagen (GO:0005518). GO:0050840 (extracellular
matrix binding) is the parent term of collagen binding and represents
SPOCK3's broader capacity to interact with ECM molecules. The
experimental evidence shows SPOCK3 is deposited on and interacts with
collagen matrices (PMID:12810672, PMID:11751414). This ECM binding
function is essential for SPOCK3 to localize properly and exert its MMP
inhibitory and cell motility regulatory functions in the extracellular
space.
supported_by:
- reference_id: PMID:12810672
supporting_text: "N-Tes deposited on collagen"
- reference_id: PMID:11751414
supporting_text: "suppressed their invasive growth in collagen gel"
- term:
id: GO:0010951
label: negative regulation of endopeptidase activity
evidence_type: IDA
original_reference_id: PMID:11751414
review:
summary: SPOCK3 negatively regulates endopeptidase activity by inhibiting
MT-MMPs. This annotation is present in UniProt GO lines but missing from
the GOA file.
action: NEW
reason: This annotation is present in the UniProt entry (line 289 -
"GO:0010951 P:negative regulation of endopeptidase activity;
IDA:UniProtKB") but was not in the GOA file. This is a biological
process term describing the regulatory role of SPOCK3's molecular
function (metalloendopeptidase inhibitor activity). PMID:11751414
provides direct experimental evidence that SPOCK3/N-Tes "interfered with
pro-MMP-2 activation" by inhibiting the endopeptidase activity of
MT1-MMP and MT3-MMP. This is a more specific biological process term
than just "negative regulation of cell motility" and directly describes
the mechanistic process by which SPOCK3 acts as an MMP inhibitor. This
should be included as it captures the regulatory aspect of SPOCK3's core
function.
supported_by:
- reference_id: PMID:11751414
supporting_text: "Using expression cloning to screen a human fetal kidney
cDNA library for regulator(s) of pro-matrix metalloproteinase (MMP)-2
processing mediated by membrane-type (MT) 1 MMP, we isolated a cDNA whose
product interfered with pro-MMP-2 activation. [...] Pro-MMP-2 activation
by MT3-MMP was also inhibited by the coexpression of N-Tes."
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms.
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword
mapping
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation
data to orthologs using Ensembl Compara.
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
findings: []
- id: PMID:11751414
title: Suppression of membrane-type 1 matrix metalloproteinase
(MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its
splicing variant gene product, N-Tes.
findings: []
- id: PMID:12810672
title: Testican 2 abrogates inhibition of membrane-type matrix
metalloproteinases by other testican family proteins.
findings: []
- id: PMID:32055794
title: 3D mapping of native extracellular matrix reveals cellular responses
to the microenvironment.
findings: []
- id: PMID:33266304
title: 'Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly
Approach to Proteomic Matrisome Characterization.'
findings: []
- id: file:human/SPOCK3/SPOCK3-uniprot.txt
title: UniProt entry for SPOCK3 (Q9BQ16)
findings: []
- id: file:human/SPOCK3/SPOCK3-deep-research-falcon.md
title: Deep research report on SPOCK3
findings: []
core_functions:
- description: SPOCK3 functions as a tumor-suppressive metalloendopeptidase
inhibitor in the extracellular matrix. It directly interacts with and
inhibits MT1-MMP and MT3-MMP, preventing pro-MMP-2 activation, which
blocks cell motility and tumor invasion. This MMP inhibitory activity is
mediated through its modular domain architecture and calcium-binding
domains.
molecular_function:
id: GO:0008191
label: metalloendopeptidase inhibitor activity
directly_involved_in:
- id: GO:2000146
label: negative regulation of cell motility
- id: GO:0010951
label: negative regulation of endopeptidase activity
locations:
- id: GO:0031012
label: extracellular matrix
- id: GO:0005615
label: extracellular space
supported_by:
- reference_id: PMID:11751414
supporting_text: "Pro-MMP-2 activation by MT3-MMP was also inhibited by the
coexpression of N-Tes. Immunoprecipitation analysis demonstrated direct
interaction of N-Tes with either MT1-MMP or MT3-MMP."
- reference_id: PMID:12810672
supporting_text: "The inhibitory function is common among testican family
members except for testican 2"
- reference_id: PMID:11751414
supporting_text: "Transfection of either the N-Tes or testican 3 gene into
U251 glioma cells or Madin-Darby canine kidney cells transformed by erbB2
suppressed their invasive growth in collagen gel."